SCHEMBL5663511

SCHEMBL5663511

CCC(Oc1ccc(OS(C)(=O)=O)cc1)Oc1cccc(OC(C)(C)C(=O)O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 11/20 0.46
▸ PPARG P37231 11/20 0.46
▸ PTPN7 P35236 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PTPN12 Q05209 1/20 0.39
▸ PTPN22 Q9Y2R2 1/20 0.39
▸ PPARD Q03181 4/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.37
▸ CYP4F2 P78329 1/20 0.36
▸ CYP4A11 Q02928 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5660182 0.95 PPARA (0.47) PPARAPPARGPTPN7DUSP3PTPN12
SCHEMBL5660424 0.92 PPARG (0.48) PPARAPPARGPPARDCYP2C19MEN1
SCHEMBL5660646 0.88 PPARA (0.48) PPARAPPARGCYP1A2CYP3A4ALDH1A1
SCHEMBL5662419 0.85 PPARG (0.42) PPARAPPARGMEN1KMT2AMAPT
SCHEMBL5660954 0.83 PPARA (0.50) PPARAPPARGCYP1A2CYP3A4ALDH1A1
SCHEMBL5659323 0.81 PPARA (0.54) PPARAPPARGPPARDCYP4F2CYP4A11
SCHEMBL5660524 0.80 ADORA3 (0.46) PPARAPPARGCYP2C19MEN1KMT2A
SCHEMBL5663198 0.79 PPARA (0.54) PPARAPPARGCYP1A2CYP3A4ALDH1A1
SCHEMBL5660178 0.78 PPARA (0.53) PPARAPPARGPPARDCYP4F2CYP4A11
SCHEMBL5659854 0.75 PPARG (0.61) PPARAPPARGPPARDCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093476-A1 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2007-04-26 — — US claimed
US-20070093476-A1 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093476-A1 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them GPR119, NR1H3, NR1H2 PPARA 251/4885PPARG 170/4885PTPN7 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback